• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血行转移中的周细胞:机制见解与治疗方法

Pericytes in hematogenous metastasis: mechanistic insights and therapeutic approaches.

作者信息

Xu Shuo, Zhang Hong, Tian Yu

机构信息

Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.

出版信息

Cell Oncol (Dordr). 2025 May 20. doi: 10.1007/s13402-025-01073-6.

DOI:10.1007/s13402-025-01073-6
PMID:40392500
Abstract

Metastasis, the leading cause of cancer-related deaths, underscores the critical need to understand its regulatory mechanisms to improve prevention and treatment strategies for late-stage tumors. Hematogenous dissemination is a key route of metastasis. However, as the gatekeeper of vessels, the role of pericytes in hematogenous metastasis remains largely unknown. In this review, we comprehensively explore the contributions of pericytes throughout the metastatic cascade, particularly their functions that extend beyond influencing tumor angiogenesis. Pericytes should not be perceived as passive bystanders, but rather as active participants in various stages of the metastatic cascade. Pericytes-targeted therapy may provide novel insights for preventing and treating advanced-stage tumor.

摘要

转移是癌症相关死亡的主要原因,这凸显了深入了解其调控机制对于改善晚期肿瘤预防和治疗策略的迫切需求。血行播散是转移的关键途径。然而,作为血管的守护者,周细胞在血行转移中的作用在很大程度上仍不清楚。在这篇综述中,我们全面探讨了周细胞在整个转移级联反应中的作用,特别是其超出影响肿瘤血管生成的功能。周细胞不应被视为被动旁观者,而应被视为转移级联反应各个阶段的积极参与者。靶向周细胞的治疗可能为晚期肿瘤的防治提供新的思路。

相似文献

1
Pericytes in hematogenous metastasis: mechanistic insights and therapeutic approaches.血行转移中的周细胞:机制见解与治疗方法
Cell Oncol (Dordr). 2025 May 20. doi: 10.1007/s13402-025-01073-6.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.用于指导复发或转移性癌症患者进行匹配靶向治疗的下一代测序技术。
Cochrane Database Syst Rev. 2025 Mar 24;3(3):CD014872. doi: 10.1002/14651858.CD014872.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Pain Assessment疼痛评估
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
8
Molecular-targeted first-line therapy for advanced gastric cancer.晚期胃癌的分子靶向一线治疗
Cochrane Database Syst Rev. 2016 Jul 19;7(7):CD011461. doi: 10.1002/14651858.CD011461.pub2.
9
Short-Term Memory Impairment短期记忆障碍
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Pericytes recruited by CCL28 promote vascular normalization after anti-angiogenesis therapy through RA/RXRA/ANGPT1 pathway in lung adenocarcinoma.趋化因子 28 募集的周细胞通过 RA/RXRA/ANGPT1 通路促进抗血管生成治疗后的肺腺癌血管正常化。
J Exp Clin Cancer Res. 2024 Jul 29;43(1):210. doi: 10.1186/s13046-024-03135-3.
2
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF).尼达尼布作为一线治疗后进展的分化型或髓样甲状腺癌患者二线治疗的安全性和有效性。欧洲癌症研究与治疗组织(EORTC)内分泌工作组的一项随机II期研究(方案1209-EnTF)。
Front Endocrinol (Lausanne). 2024 Jun 27;15:1403687. doi: 10.3389/fendo.2024.1403687. eCollection 2024.
3
Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.内皮细胞唾液酸糖蛋白受体在癌症中的表达模式、作用机制及治疗方法。
Theranostics. 2024 Jan 1;14(1):379-391. doi: 10.7150/thno.89495. eCollection 2024.
4
Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites.从冷到热:基于 PDGFB 纳米复合材料促进血管正常化的肿瘤免疫治疗。
Small. 2024 Apr;20(16):e2308638. doi: 10.1002/smll.202308638. Epub 2023 Nov 28.
5
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression.用一种α 型 1 极化树突状细胞疫苗靶向周细胞抗原 DLK1 可导致肿瘤血管调节和防止结肠癌进展。
Front Immunol. 2023 Oct 2;14:1241949. doi: 10.3389/fimmu.2023.1241949. eCollection 2023.
6
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection.基于李斯特菌的 RGS5 周细胞抗原疫苗接种可引发抗血管作用和结肠癌保护。
Oncoimmunology. 2023 Sep 28;12(1):2260620. doi: 10.1080/2162402X.2023.2260620. eCollection 2023.
7
Stromal cells in the tumor microenvironment: accomplices of tumor progression?肿瘤微环境中的基质细胞:肿瘤进展的帮凶?
Cell Death Dis. 2023 Sep 4;14(9):587. doi: 10.1038/s41419-023-06110-6.
8
TCAF2 in Pericytes Promotes Colorectal Cancer Liver Metastasis via Inhibiting Cold-Sensing TRPM8 Channel.周皮细胞中的 TCAF2 通过抑制冷敏感受型 TRPM8 通道促进结直肠癌肝转移。
Adv Sci (Weinh). 2023 Oct;10(30):e2302717. doi: 10.1002/advs.202302717. Epub 2023 Aug 27.
9
CD44 lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration.CD44 肺癌干细胞衍生的周细胞样细胞通过 GPR124 增强的跨内皮迁移导致脑转移。
Cancer Cell. 2023 Sep 11;41(9):1621-1636.e8. doi: 10.1016/j.ccell.2023.07.012. Epub 2023 Aug 17.
10
Friend or foe? The elusive role of hepatic stellate cells in liver cancer.友敌?肝星状细胞在肝癌中的复杂作用。
Nat Rev Gastroenterol Hepatol. 2023 Oct;20(10):647-661. doi: 10.1038/s41575-023-00821-z. Epub 2023 Aug 7.